Healthcare's persistent underperformance over the past two years has been a source of concern for investors, with political uncertainty in the United States, rising interest rates, and the gravitational pull of capital towards AI and technology stocks all contributing to the sector's struggles. However, beneath the headline weakness, the healthcare sector's fundamentals remain in good shape across multiple sub-sectors, even as share prices have failed to reflect this. This presents an opportunity for wealth allocators to re-engage with the sector, particularly at depressed valuations. In this article, I will explore the key drivers of healthcare's current dislocation, the structural imperatives for innovation and M&A, and the potential for a meaningful rerating in the sector. I will also discuss the role of AI within healthcare and its impact on the sector's economics, as well as the defensive qualities and innovation-driven growth that make healthcare an increasingly logical complement to concentrated technology positions. Finally, I will consider the broader implications of healthcare's valuation disconnect and the potential for wealth allocators to capitalize on the current dislocation.
